Compare NRC & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | ISD |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 428.2M |
| IPO Year | 1997 | N/A |
| Metric | NRC | ISD |
|---|---|---|
| Price | $17.13 | $12.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 100.0K | ★ 102.9K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | 3.65% | ★ 9.69% |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 50.00 | N/A |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.35 | ★ N/A |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $9.76 | $11.82 |
| 52 Week High | $22.79 | $14.79 |
| Indicator | NRC | ISD |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 22.76 |
| Support Level | $14.78 | N/A |
| Resistance Level | $18.29 | $14.64 |
| Average True Range (ATR) | 0.91 | 0.26 |
| MACD | 0.15 | -0.06 |
| Stochastic Oscillator | 52.12 | 5.77 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.